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In a laboratory setting, severe acute respiratory syndrome coro-navirus 2 (SARS-CoV-2) was inoculated into human bronchial epithelial cells. This inoculation, which was performed in a biosafety level 3 facility, had a 
multiplicity of infection (indicating the ratio of virus particles to targeted airway 
cells) of 3:1. These cells were then examined 96 hours after infection with the use 
of scanning electron microscopy. An en face image (Panel A) shows an infected 
ciliated cell with strands of mucus attached to the cilia tips. At higher magnifica-
tion, an image (Panel B) shows the structure and density of SARS-CoV-2 virions 
produced by human airway epithelial cells. Virus production was approximately 
3×106 plaque-forming units per culture, a finding that is consistent with a high 
number of virions produced and released per cell.
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